I don't understand why you would progress to phase 3 and the costs involved in that if you're aware the phase 2 results are lacking
Probably to keep the stock price elevated till they can raise new funds, management can cash out, other product candidates can progress to more promising stages etc.I don't understand why you would progress to phase 3 and the costs involved in that if you're aware the phase 2 results are lacking
We already have the results, they leaked. Increase in haircount was similar to finasterideThat's the whole point; the trial is finished ages ago but for some reason they keep delaying its publication. It is obviously a financial decision. Hopefully it is because the results are so f*****g good that they want to inside trade before publishing. But lets be honest, most likely the results aren't good.
They said the data would be presented in a symposium in June. Yea man it feels like they are always hiding somthing and that what makes us skeptical...But it's just an online release? Or it's a proper dermatology conference? Because it's odd that they said in ''June'' and not the specific day/time...